Vaccine maker stocks decline after Trump nominates RFK Jr. for health department role

nbcnews.com

Stocks of vaccine manufacturers dropped sharply on Thursday after President-elect Donald Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy is known for his skepticism about vaccines. Moderna's shares fell over 5%, Novavax dropped more than 7%, and Pfizer's stock decreased by over 2%. BioNTech and GSK also saw declines, with BioNTech down more than 6% and GSK roughly 2% lower. The decline in stock prices continued after Trump confirmed Kennedy's nomination on social media. Health experts have raised concerns that Kennedy's appointment could increase anti-vaccine sentiment in the U.S.


With a significance score of 3.8, this news ranks in the top 12% of today's 17973 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 9000 minimalists.